Outcome of catheter ablation of atrial fibrillation in patients with prior ischemic stroke

Chinese Medical Journal

Volumn 126, Issue 6, 2013, Pages 1033-1038

  Li, Song Nan ^a   Kang, Jun Ping ^a   Du, Xin ^a   He, Xiao Nan ^a   Long, De Yong ^a   Yu, Rong Hui ^a   Tang, Ri Bo ^a   Sang, Cai Hua ^a   Jiang, Chen Xi ^a   Ning, Man ^a   Dong, Jian Zeng ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Recurrence; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CATHETER ABLATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RISK FACTOR; SINUS RHYTHM; TRANSIENT ISCHEMIC ATTACK;

AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE;

EID: 84876923094     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20123406     Document Type: Article

References (30)

1. Go AD, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
3. Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27: 1760-1764.
4. Sage JI, Van Uitert RL. Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease. Stroke 1983; 14: 537-540.
5. Tang RB, Liu DL, Dong JZ, Liu XP, Long DY, Yu RH, et al. High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2010; 74: 1316-1321.
6. Miao CL, Yin XD, Dong JZ, Liu XP, Yu RH, Long DY, et al. Catheter ablation of persistent atrial fibrillation with and without a history of paroxysmal atrial fibrillation. Chin Med J 2012; 125: 1175-1178.
7. Chen Z. The mortality and death cause of national sample areas. In: Chen Z, ed. The third national survey on the cause of death, 1st ed. Beijing: Peking Union Medical University Press; 2008: 14-15.
8. Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, et al; Collaborative Group of China Multicenter Study of Cardiovascular Epidemiology. Proportion of different subtypes of stroke in China. Stroke 2003; 34: 2091-2096.
9. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987; 147: 1561-1564.
10. Arboix A, Cendrós V, Besa M, García-Eroles L, Oliveres M, Targa C, et al. Trends in risk factor, stroke subtypes, and outcome: nineteen-year data from the Sagrat Cor Hospital of the Barcelona Stroke Registry. Cerebrovasc Dis 2008; 26: 509-516.
11. Appelros P, Nydevik I, Seiger A, Terént A. Predictors of severe stroke: influence of preexisting dementia and cardiac disorders. Stroke 2002; 33: 2357-2362.
12. Saxena R, Lewis S, Berge E, Sandercock PA, Koudstaal PJ. Risk of early death and recurrent stroke and effect of heparin in 3169 patients with acute ischemic stroke and atrial fibrillation in the International Stroke Trial. Stroke 2001; 32: 2333-2337.
13. Fischer U, Arnold M, Nedeltchev K, Schoenenberger RA, Kappeler L, Hollinger P. et al. Impact of comorbidity on ischemic stroke outcome. Acta Neurol Scand 2006; 113: 108-113.
14. Goldstein LB, Samsa GP, Matchar DB, Horner RD. Charlson Index comorbidity adjustment for ischemic stroke outcome studies. Stroke 2004; 35: 1941-1945.
15. Thygesen SK, Frost L, Eagle KA, Johnsen SP Atrial fibrillation in patients with ischemic stroke: a population-based study. Clin Epidemiol 2009; 1: 55-65.
16. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994; 25: 333-337.
17. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke 2004; 35: 731-735.
18. Lovett JK, Coull AJ, Rothwell PM. Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies. Neurology 2004; 62: 569-573.
19. Purroy F, Montaner J, Molina CA, Delgado P, Ribo M, Alvarez-Sabín J. Patterns and predictors of early risk of recurrence after transient ischemic attack with respect to etiologic subtypes. Stroke 2007; 38: 3225-3229.
20. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Journal 2010; 31: 2369-2429.
21. Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, et al. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Heart Rhythm 2012; 8: 157-176.
22. Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42: 227-276.
23. Zhou ZQ, Hu DY, Chen J, Zhang RH, Li KB, Zhao XL. An epidemiological survey of atrial fibrillation in China. Chin J Intern Med (Chin) 2004; 43: 491-494.
24. Lin S, Wu B, Hao ZL, Kong FY, Tao WD, Wang DR, et al. Characteristics, treatment and outcome of ischemic stroke with atrial fibrillation in a Chinese hospital-based stroke study. Cerebrovasc Dis 2011; 31: 419-426.
25. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012; 14: 528-606.
26. Themistoclakis S, Corrado A, Marchlinski FE, Jais P, Zado E, Rossillo A, et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010; 55: 735-743.
27. 2 score <3: a long-term outcome study. Circ Arrhythm Electrophysiol 2011; 4: 615-621.
28. Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, et al. Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death. Heart 2012; 98: 48-53.
29. Lin YJ, Chao TF, Tsao HM, Chang SL, Lo LW, Chiang CE, et al. Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher. Europace 2012; Epub ahead of print.
30. Chao TF, Tsao HM, Lin YJ, Tsai CF, Lin WS, Chang SL, et al. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol 2012; 5: 514-520.